Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Infectious Diseases and Their Occurrence

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...

Preventive Healthcare Services

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biosynthesis of glycosylated 5-hydroxycytosine in the DNA of diverse viruses.

Nucleic acids research·2026

Same author

Special Issue: Novel Vaccines and Vaccine Technologies for Emerging Infections.

Vaccines·2026

Same author

Durability of DNA-LNP and mRNA-LNP vaccine-induced immunity against SARS-CoV-2 XBB.1.5.

NPJ vaccines·2026

Same author

Bacteriophages as vaccine platforms: Opportunities and challenges in translation.

Human vaccines & immunotherapeutics·2025

Same author

Synthesis of α,ε-<i>N</i>,<i>N</i>'-Di-stearoyl Lysine-Derived Amide Lipids and Their Application to Liposome Formulation: Incorporation of Lipid A-Ligand for Bacterial Targeting and Sialic Acid for Phagocytosis Resistance.

International journal of molecular sciences·2025

Same author

Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses.

Antiviral research·2025

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

6th Annual Vaccines: all things considered.

Wangxue Chen¹, Rhonda Kuolee

¹National Research Council Canada, Institute for Biological Sciences, 100 Sussex Drive, Room 3100, Ottawa, ON K1A 0R6, Canada. wangxue.chen@nrc-cnrc.gc.ca

Expert Review of Vaccines

|March 3, 2009

Summary

The 6th Annual Vaccines conference convened researchers to discuss novel vaccine developments, regulatory insights, and emerging technologies. Key topics included advancements in vaccine research, policy updates, and innovative approaches shaping the future of immunization.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Remote Laboratory Management: Respiratory Virus Diagnostics

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Related Experiment Videos

Last Updated: Jun 25, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Remote Laboratory Management: Respiratory Virus Diagnostics

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Area of Science:

Vaccinology
Immunology
Public Health Policy

Background:

The 6th Annual Vaccines: All Things Considered conference provided a platform for interdisciplinary dialogue.
Researchers from academia, industry, and government convened to share updates on vaccine research and development.

Framework:

The conference facilitated discussions on novel vaccine developments.
It addressed current regulatory perspectives and government policies impacting vaccine deployment.
Emerging technologies in vaccine formulation and delivery were also a key focus.

Implementation:

The 2-day event featured two keynote addresses, 20 oral presentations, and 15 poster sessions.
Approximately 80 delegates, including many from European nations, attended the conference.
A tradition of selecting two posters for oral presentation highlighted promising research.

Implications:

The meeting report synthesizes key issues and advancements discussed.
It offers insights into the evolving landscape of vaccine science and policy.
The conference fostered collaboration and knowledge exchange among global vaccine experts.